Precision-fermented lamb protein clears FDA, opening a new ingredient class for pet food

The first animal protein made by precision fermentation cleared FDA's Center for Veterinary Medicine review on Tuesday, opening a regulatory path that every major pet food brand will now have to weigh against its own protein strategy. The ingredient, Lamb Protein Yeast, is approved for use in healthy adult dog food at inclusion levels up to 15%.

Bond Pet Foods clears FDA GRAS review for Lamb Protein Yeast

Bond Pet Foods received an FDA Center for Veterinary Medicine Letter of No Objection on its Generally Recognized as Safe (GRAS) Notice for Lamb Protein Yeast, the company and Hill's Pet Nutrition announced on May 12. It is the first animal protein produced via precision fermentation to clear the agency's review for U.S. pet food.

The ingredient was developed jointly with Hill's, a Colgate-Palmolive subsidiary, under a partnership that began in 2021. Bond produced more than 25 metric tons of the ingredient at commercial scale and shipped it to Hill's facilities for formulation, testing, and regulatory work.

The dog clearance covers inclusion levels of up to 15% of the finished food in healthy adult dogs, following a six-month longitudinal feeding study. The two companies say a separate feeding study in cats is complete and that additional materials supporting feline use are being prepared for submission to FDA.

Bond has raised $17.5 million in Series A funding (September 2022) on top of roughly $2.5 million in earlier capital, backed by ADM Ventures, Cavallo Ventures (Wilbur-Ellis), Symrise AG, Agronomics, Lever VC, Genoa Ventures, KBW Ventures, iSelect Fund, and Plug and Play Ventures. Symrise added strategic investment in April 2026.

Bond did not disclose a commercial launch date for finished Hill's products containing the ingredient.

A new protein class lands inside the largest pet food company's R&D pipeline

The story behind the headline is the regulatory template, not the ingredient. Precision fermentation has had a brutal commercialization decade in human food — Perfect Day, Motif, Nature's Fynd, and others have hit the wall on price, taste, or shelf placement. Pet food is a different problem set. Brands compete on functional and sourcing claims rather than parity to meat, and the rendering supply chain is already volatile enough that buyers are paying for reliability. A fermentation-derived animal protein lands in a category that's primed to absorb it.

Hill's now holds first-mover position on a protein category that took five years and an undisclosed multi-million-dollar commitment to build. Every other top-tier brand — Mars Petcare (Royal Canin, IAMS, Eukanuba), Nestlé Purina, General Mills (Blue Buffalo), Wellness Pet Company, Freshpet, Spectrum Brands — now has to decide whether to license, partner, acquire, or build a parallel platform. Mars has internal alt-protein work via Kind Earth; Purina has sustainability-positioned R&D; Freshpet does not. The buyer side of the M&A market for fermentation startups got more crowded today.

The rendering and meat-meal supply chain is the second-order story. U.S. pet food consumes roughly a third of all rendered meat-meal output domestically, and rendering margins have been compressed by tariff uncertainty and beef-herd contraction. A high-quality, GRAS-cleared fermentation protein lets Hill's reduce its exposure to commodity meat-meal volatility on the most premium tier of its portfolio. Other brands will model that math next.

Co-manufacturers should expect calls. The next twelve months of fermented-protein commercialization run through whoever can ferment at scale and ship dry powder. Bond has not named a contract manufacturer publicly. That supplier list will become a proxy for who reaches the shelf in 2027.

What this clearance does not solve: cost parity, label perception, and feline use. Lamb Protein Yeast is approved in dogs, capped at 15% inclusion. It will go into premium SKUs first, and likely at lower inclusion than the cap allows, because economics in commodity dog food still favor rendered meal.

What to watch as Bond moves toward commercial launch

The first product SKU is the next signal. Hill's has not announced which line — Science Diet, Prescription Diet, or a new sub-brand — carries the ingredient first. The launch tier will tell operators whether Hill's plans to use precision fermentation as a margin play (Prescription Diet) or a positioning play (a sustainability-led sub-brand). Both are plausible.

Feline submission: A second GRAS no-objection covering cats would roughly double the addressable category. The companies signaled the submission is imminent. Watch the FDA Center for Veterinary Medicine notice board over the next quarter.

Competitor response: Mars and Purina have both been quiet on precision fermentation; expect at least one public commitment within 90 days, either an acquisition, a partnership announcement, or an in-house program disclosure.

Bond Series B: With FDA clearance and a marquee customer, Bond's next funding round becomes a strategic process rather than a venture one. Strategic investors already in the cap table — ADM, Wilbur-Ellis, Symrise — set a floor on optionality.

Inclusion cap creep: The 15% cap reflects the data submitted, not a technical limit. A future submission expanding inclusion levels would unlock higher-meat formulations and shift the economics of using fermentation protein versus rendered meal.

Related Analysis

Source: Hill's Pet Nutrition and Bond Pet Foods Receive FDA No-Objection Letter via PR Newswire